Why the study?
Does short-term enoxaparin administration reduce tissue factor levels and hypercoagulability in patients with unstable angina?
Does short-term enoxaparin administration reduce tissue factor levels and hypercoagulability in patients with unstable angina?
Short-term enoxaparin administration in unstable angina patients reduces tissue factor levels and hypercoagulability, indicating a novel mechanism of action for low-molecular-weight heparins.
Answers are grounded in this paper and cite their sources.
May support enoxaparin's antithrombotic effects beyond anticoagulation in unstable angina; hypothesis-generating and requires randomized confirmation before practice change.
High tissue factor (TF), tissue factor pathway inhibitor (TFPI) levels and a hypercoagulability state have been documented in unstable angina patients. We evaluated whether short-term enoxaparin administration (100 IU/kg b.i.d. for 3 d) reduces the high TF levels and the hypercoagulability state, and whether it influences the fibrinolytic system in 20 unstable angina patients. On d 3, we observed a significant reduction in TF levels both 1 h and 4 h after the morning injection (-25.6% and -21.7%; P < 0.001 respectively) in comparison with the base-line levels. Both 1 and 4 h after the morning injection on the d 3, TFPI levels significantly (P < 0.001) increased (+96.4%, +96.9% respectively) with respect to the base-line values. After enoxaparin administration, at all observation times, thrombin-antithrombin complexes and prothrombin fragment F1 + 2 levels were significantly (P < 0.001) lower with respect to base-line levels. We observed a slight but significant increase in tissue plasminogen activator antigen levels in preinjection samples, as well as 1 h and 4 h after enoxaparin administration, in comparison with the base-line values. This study provides evidence that low-molecular-weight heparin (LMWH) administration, in addition to a reduction of hypercoagulability and a mild fibrinolytic activation, is associated with decreased TF levels, so indicating a novel mechanism of interference of LMWH with the haemostatic system.
No takes yet. Share an insight, caveat, or question.
Gori et al. (2002) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: